The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow–Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats-Reference-Cited by-同舟云学术

The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow–Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats

Published:2019-10-23 Issue:1 Volume:43 Page:123-134
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Gad E. S.^ORCID,Salama A. A. A.,El-Shafie M. F.,Arafa H. M. M.,Abdelsalam R. M.,Khattab M.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s10753-019-01101-2.pdf

Reference41 articles.

1. Raghu, G., K.K. Brown, H.R. Collard, V. Cottin, K.F. Gibson, R.J. Kaner, D.J. Lederer, F.J. Martinez, P.W. Noble, J.W. Song, A.U. Wells, T.P. Whelan, W. Wuyts, E. Moreau, S.D. Patterson, V. Smith, S. Bayly, J.W. Chien, Q. Gong, J.J. Zhang, and T.G. O’Riordan. 2017. Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial. The Lancet Respiratory Medicine 5: 22–32.

2. Chandler, D.B. 1990. Possible mechanisms of bleomycin-induced fibrosis. Clinics in Chest Medicine 11: 21–30.

3. Douglas, W.W., J.H. Ryu, and D.R. Schroeder. 2000. Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival. American Journal of Respiratory and Critical Care Medicine 161: 1172–1178.

4. Horowitz, J.C., Z. Cui, T.A. Moore, T.R. Meier, R.C. Reddy, G.B. Toews, T.J. Standiford, and V.J. Thannickal. 2006. Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome. American Journal of Physiology. Lung Cellular and Molecular Physiology 290: L415–L425.

5. Biernacka, A., M. Cavalera, J. Wang, I. Russo, A. Shinde, P. Kong, C. Gonzalez-Quesada, V. Rai, M. Dobaczewski, D.W. Lee, X.F. Wang, and N.G. Frangogiannis. 2015. Smad3 signaling promotes fibrosis while preserving cardiac and aortic geometry in obese diabetic mice. Circulation. Heart Failure 8: 788–798.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microvesicles derived from mesenchymal stem cells inhibit acute respiratory distress syndrome-related pulmonary fibrosis in mouse partly through hepatocyte growth factor;World Journal of Stem Cells;2024-08-26

2. Epithelial–mesenchymal transition in chemoradiation‐induced lung damage: Mechanisms and potential treatment approaches;Journal of Biochemical and Molecular Toxicology;2024-08

3. BMSCs promote alveolar epithelial cell autophagy to reduce pulmonary fibrosis by inhibiting core fucosylation modifications;Stem Cells;2024-07-10

4. The potential ameliorating effect of vitamin E on bleomycin − induced lung fibrosis in adult albino rats;International Immunopharmacology;2024-07

5. Stem cell-based therapy for fibrotic diseases: mechanisms and pathways;Stem Cell Research & Therapy;2024-06-18